Millennium Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$147M Buy
675,757
+655,864
+3,297% +$145M 0.06% 303
2025
Q4
$4.55M Sell
19,893
-1,995,849
-99% -$455M ﹤0.01% 3117
2025
Q3
$467M Sell
2,015,742
-430,865
-18% -$87.7M 0.2% 55
2025
Q2
$454M Buy
2,446,607
+1,972,337
+416% +$367M 0.22% 48
2025
Q1
$99.4M Buy
474,270
+275,220
+138% +$53.5M 0.05% 354
2024
Q4
$35.4M Sell
199,050
-895,933
-82% -$165M 0.02% 1038
2024
Q3
$216M Buy
1,094,983
+114,751
+12% +$21.4M 0.1% 151
2024
Q2
$168M Buy
980,232
+854,846
+682% +$142M 0.08% 243
2024
Q1
$22.8M Sell
125,386
-657,764
-84% -$113M 0.01% 1454
2023
Q4
$121M Sell
783,150
-816,663
-51% -$119M 0.05% 345
2023
Q3
$238M Buy
1,599,813
+488,873
+44% +$71.8M 0.12% 115
2023
Q2
$150M Buy
1,110,940
+171,401
+18% +$25.1M 0.07% 198
2023
Q1
$150M Buy
939,539
+807,485
+611% +$123M 0.09% 184
2022
Q4
$21.3M Sell
132,054
-505,224
-79% -$77.5M 0.01% 1386
2022
Q3
$85.5M Buy
637,278
+548,224
+616% +$78.7M 0.05% 412
2022
Q2
$13.6M Sell
89,054
-362,772
-80% -$55.4M 0.01% 1688
2022
Q1
$73.2M Sell
451,826
-422,005
-48% -$61.3M 0.04% 485
2021
Q4
$118M Buy
873,831
+232,675
+36% +$27.5M 0.06% 290
2021
Q3
$69.2M Sell
641,156
-361,369
-36% -$41.3M 0.04% 473
2021
Q2
$113M Buy
1,002,525
+973,668
+3,374% +$110M 0.07% 260
2021
Q1
$3.12M Sell
28,857
-91,395
-76% -$9.78M ﹤0.01% 3099
2020
Q4
$12.9M Sell
120,252
-43,572
-27% -$4.19M 0.01% 1466
2020
Q3
$14.3K Sell
163,824
-705,346
-81% -$66.4M 0.02% 994
2020
Q2
$85.3M Buy
869,170
+102,886
+13% +$9.06M 0.12% 137
2020
Q1
$58.4M Sell
766,284
-969
-0.1% -$82.5K 0.13% 136
2019
Q4
$67.9M Buy
767,253
+663,952
+643% +$55.1M 0.09% 246
2019
Q3
$7.82M Sell
103,301
-687,799
-87% -$47.2M 0.01% 1458
2019
Q2
$57.5M Buy
791,100
+376,277
+91% +$29.6M 0.09% 284
2019
Q1
$33.4M Buy
+414,823
New +$33.9M 0.05% 519
2018
Q4
Sell
-1,635,376
Closed -$144M 3695
2018
Q3
$155M Sell
1,635,376
-1,075,736
-40% -$102M 0.19% 85
2018
Q2
$251M Buy
2,711,112
+1,864,703
+220% +$182M 0.33% 23
2018
Q1
$80.1M Buy
846,409
+572,179
+209% +$62.9M 0.11% 249
2017
Q4
$26.5M Sell
274,230
-222,855
-45% -$21M 0.04% 725
2017
Q3
$44.2M Sell
497,085
-1,565,800
-76% -$119M 0.07% 395
2017
Q2
$150M Buy
2,062,885
+1,044,203
+103% +$70.2M 0.27% 55
2017
Q1
$66.4M Buy
1,018,682
+127,405
+14% +$8.01M 0.12% 228
2016
Q4
$55.8M Buy
891,277
+282,223
+46% +$17.2M 0.12% 227
2016
Q3
$38.4M Buy
+609,054
New +$39.4M 0.06% 320
2016
Q2
Sell
-241,405
Closed -$13.8M 3128
2016
Q1
$13.8M Buy
+241,405
New +$13.5M 0.03% 647
2015
Q4
Sell
-992,641
Closed -$57.2M 3365
2015
Q3
$54M Buy
992,641
+267,329
+37% +$17.4M 0.1% 223
2015
Q2
$48.7M Sell
725,312
-85,766
-11% -$5.6M 0.09% 264
2015
Q1
$47.5M Sell
811,078
-325,690
-29% -$19.7M 0.09% 290
2014
Q4
$74.4M Sell
1,136,768
-3,155,201
-74% -$199M 0.16% 125
2014
Q3
$248M Buy
4,291,969
+1,500,525
+54% +$83.3M 0.63% 7
2014
Q2
$158M Buy
2,791,444
+1,063,299
+62% +$55.8M 0.44% 23
2014
Q1
$88.8M Buy
1,728,145
+1,284,689
+290% +$64.9M 0.26% 59
2013
Q4
$23.4M Sell
443,456
-575,318
-56% -$28.3M 0.07% 289
2013
Q3
$45.6M Sell
1,018,774
-343,831
-25% -$15.2M 0.15% 100
2013
Q2
$56.3M Buy
+1,362,605
New +$59.6M 0.17% 60

Other funds holding ABBV

Millennium Management's ABBV Position: Q1 2026 in Review

Millennium Management increased its AbbVie (ABBV) stake by 3,297% in Q1 2026, buying an estimated $145M and bringing the position to 675,757 shares worth $147M. The position accounts for 0.06% of the portfolio, ranked #303.

Millennium Management first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $467M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Millennium Management held 675,757 shares of AbbVie worth $147M as of Q1 2026.
  • Millennium Management bought 655,864 AbbVie shares in Q1 2026, an estimated $145M.
  • AbbVie made up 0.06% of Millennium Management's portfolio in Q1 2026, its #303 holding.
  • Millennium Management first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
  • Millennium Management's AbbVie position peaked at $467M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.